# BRITISH SOCIETY OF BLOOD AND MARROW TRANSPLANTATION AND CELLULAR THERAPY

## Details

- **Country:** England &amp; Wales
- **Charity number:** 1125795
- **Other names:** BRITISH SOCIETY OF BLOOD AND MARROW TRANSPLANTATION
- **Status:** Registered
- **Legal form:** Charitable company
- **Company number:** [06462720](https://find-and-update.company-information.service.gov.uk/company/06462720)
- **Registered:** Sept. 9, 2008
- **Register:** https://register-of-charities.charitycommission.gov.uk/en/charity-search/?p_p_id=uk_gov_ccew_onereg_charitydetails_web_portlet_CharityDetailsPortlet&amp;p_p_lifecycle=0&amp;p_p_state=maximized&amp;p_p_mode=view&amp;_uk_gov_ccew_onereg_charitydetails_web_portlet_CharityDetailsPortlet_regId=1125795


## Contact

- **Address:** BSBMTCT Data Registry, c/o Guy&#x27;s Hospital, Great Maze Pond, London
- **Postcode:** SE1 9RT
- **Phone:** 020 7188 8413
- **Email:** enquiries@bsbmt.org
- **Website:** https://bsbmtct.org/



## Activities

**Objects:** (A) TO ADVANCE HEALTH BY THE PROMOTION OF RESEARCH INTO AND THE ADVANCEMENT OF KNOWLEDGE OF THE USE OF ALLOGENEIC OR AUTOLOGOUS HAEMOPOIETIC STEM CELLS AND CELLULAR THERAPY IN THE TREATMENT OF LEUKAEMIA, LYMPHOMA, MYELOMA, AND OTHER MALIGNANT DISORDERS, NON-MALIGNANT HAEMATOLOGICAL DISORDERS INCLUDING APLASTIC ANAEMIA AND HAEMOGLOBINOPATHIES AND APPROPRIATE NON HAEMATOLOGICAL DISEASES;

**Activities:** To promote education and research in blood and marrow stem cell transplantation and cellular therapy in the UK and Republic of Ireland.




## Classification

- **How:** Provides Advocacy/advice/information, Sponsors Or Undertakes Research
- **What:** The Advancement Of Health Or Saving Of Lives
- **Who:** The General Public/mankind



## Geography

- **Area of benefit:** NATIONAL
- Northern Ireland
- Scotland
- Throughout England And Wales





## Trustees

| Name | Role | Appointed |
|---|---|---|
| Dr Deborah Susan Richardson |  | Jan. 1, 2019 |
| Dr Fiona Dignan |  | Jan. 1, 2013 |
| Dr Harpreet Kaur |  | Jan. 3, 2023 |
| Dr Victoria Potter |  | Jan. 1, 2025 |
| Prof Eduardo Olavarria |  | July 22, 2021 |




